Tim-3 and galectin-9 have shown significantly elevated expression in plasma-derived exosomes of NSCLC patients (compared to healthy individuals) and lung SCC patients (compared to lung AC patients) [129]. This evidence concerns the gene LGALS9 and non-small cell lung carcinoma.